Literature DB >> 16424925

Laboratory testing considerations for C. difficile disease.

David F Welch1.   

Abstract

Entities:  

Year:  2006        PMID： 16424925      PMCID： PMC1326024          DOI： 10.1080/08998280.2006.11928117

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  9 in total

1.  Clinical usefulness of components of the Triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrhea.

Authors:  Viki Massey; Daniel B Gregson; Abdul H Chagla; Miriam Storey; Michael A John; Zafar Hussain
Journal:  Am J Clin Pathol       Date:  2003-01       Impact factor: 2.493

2.  Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile-associated diarrhea in hospitalized patients.

Authors:  Renate J van den Berg; Lesla S Bruijnesteijn van Coppenraet; Hendrik-Jan Gerritsen; Hubert P Endtz; Eric R van der Vorm; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Colitis due to Clostridium difficile toxins: underdiagnosed, highly virulent, and nosocomial.

Authors:  John S Fordtran
Journal:  Proc (Bayl Univ Med Cent)       Date:  2006-01

4.  Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains.

Authors:  Frédéric Barbut; Dominique Decré; Valérie Lalande; Béatrice Burghoffer; Latifa Noussair; Anne Gigandon; Florence Espinasse; Laurent Raskine; Jérome Robert; Alain Mangeol; Catherine Branger; Jean-Claude Petit
Journal:  J Med Microbiol       Date:  2005-02       Impact factor: 2.472

5.  Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay.

Authors:  David K Turgeon; Thomas J Novicki; John Quick; LaDonna Carlson; Pat Miller; Bruce Ulness; Anne Cent; Rhoda Ashley; Ann Larson; Marie Coyle; Ajit P Limaye; Brad T Cookson; Thomas R Fritsche
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

6.  Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea.

Authors:  Michael S Morelli; Susan D Rouster; Ralph A Giannella; Kenneth E Sherman
Journal:  Clin Gastroenterol Hepatol       Date:  2004-08       Impact factor: 11.382

7.  A European survey of diagnostic methods and testing protocols for Clostridium difficile.

Authors:  F Barbut; M Delmée; J S Brazier; J C Petit; I R Poxton; M Rupnik; V Lalande; C Schneider; P Mastrantonio; R Alonso; E Kuipjer; M Tvede
Journal:  Clin Microbiol Infect       Date:  2003-10       Impact factor: 8.067

8.  Pseudomembranous colitis caused by toxin A-negative/toxin B-positive variant strain of Clostridium difficile.

Authors:  Masahiro Toyokawa; Akiko Ueda; Hisako Tsukamoto; Isao Nishi; Masayuki Horikawa; Atsuko Sunada; Seishi Asari
Journal:  J Infect Chemother       Date:  2003-12       Impact factor: 2.211

9.  Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens.

Authors:  L Zheng; S F Keller; D M Lyerly; R J Carman; C W Genheimer; C A Gleaves; S J Kohlhepp; S Young; S Perez; K Ye
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948
  9 in total
  1 in total

1.  Evaluation of repeat Clostridium difficile enzyme immunoassay testing.

Authors:  Diana M Cardona; Kenneth H Rand
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.